Austramedex

What Austramedex does

Austramedex is an Australian-owned medical device manufacturer and distributor founded in 1988 and headquartered in Hallam, Victoria. The company operates across three core areas: operating theatre safety (needle counters, diathermy tip cleaners, cord covers), plastic and cosmetic surgery (collagen stimulating fillers, Silhouette Soft thread lifts), and regenerative medicine (Regenera Activa AMT, E-50 Exosomes, FACTOR 4). Its products are TGA-approved and manufactured under ISO 13485:2003 quality management certification, enabling both domestic and global distribution.

The company serves a specialized clinical customer base including plastic surgeons, cosmetic doctors, aesthetic physicians, dermatologists, orthopaedic surgeons, and hospital operating theatres. Its regenerative medicine portfolio is built on proprietary autologous and exosome-based technologies—FACTOR 4 is an autologous protein treatment derived from the patient's own blood, while Regenera Activa AMT uses Autologous Micrografting Technology to harvest and process tissue for regenerative applications. The company also offers Contract Manufacturing Services to third-party medical device firms, leveraging its certified manufacturing infrastructure.

Austramedex generates revenue through one-time medical device sales to clinical practitioners and contract manufacturing fees from enterprise clients. Its go-to-market operates through direct sales to physicians and clinics, supported by a clinic finder tool that connects patients to certified providers. The company has developed sub-brands (Collagen Australia, Regenera Activa Australia, Regenera Sports Medicine) to target distinct clinical segments and has established a training partnership with Sinclair College to support physician adoption of its aesthetic and regenerative products.

Name

Austramedex

Legal name

AUSTRAMEDEX (VIC) PTY LTD

Website

https://austramedex.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

Austramedex is an Australian-owned medical device manufacturer and distributor (founded 1988, Hallam) serving plastic surgeons, cosmetic doctors, and hospitals with operating theatre safety products, aesthetic devices, and proprietary regenerative medicine technologies including exosomes and autologous treatments.

Ownership category

akta.pro rank

Product category

Aesthetic Medicine Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

Keywords

• Medical device manufacturing
• Aesthetic medicine devices
• Regenerative medicine products
• Dermal filler devices
• Surgical safety equipment

Headquarters

HQ city

Hallam

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Manufacture and supply of medical devices including collagen stimulating fillers, thread lifts, regenerative medicine products, and surgical safety equipment to healthcare professionals and clinics.
2. Contract Manufacturing Services: Offers comprehensive contract manufacturing services for medical devices including design assistance, material procurement, process development, validation, and product manufacturing for third parties seeking to enter the medical device market.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Austramedex manufactures and distributes medical devices for the operating theatre, plastic and cosmetic surgery/medicine, and regenerative medicine markets. Its core portfolio spans four aesthetic platforms (Collagen Stimulating Filler, Silhouette Soft thread lifts, Regenera Activa AMT, and supporting regenerative lines including E-50 Exosomes and FACTOR 4 PRP), single-use operating theatre safety products (Needle Counters, Diathermy Tip Cleaners, Cord Covers), and contract manufacturing services for third-party medical device producers under ISO 13485:2003 compliance.

Product overview

Austramedex is an Australian-based medical device company specializing in aesthetic medicine and regenerative products. The portfolio centers on four core aesthetic platforms: Collagen Stimulating Filler (a dual-action dermal filler), Silhouette Soft (thread lift devices), Regenera Activa AMT (autologous micrograft technology for dermatology and orthopedics), E-50 Exosomes (marine-derived regenerative exosomes), and FACTOR 4 (next-generation PRP therapy). Additionally, the company manufactures single-use surgical safety products including Needle Counters, Diathermy Tip Cleaners, and Cord Covers for operating theatres, plus offers contract manufacturing services for medical devices. All manufactured products are available for worldwide distribution.

Differentiator

Problem solved

Functional benefit

Brands

• Collagen Stimulating Filler Australia: Brand name for the collagen stimulating filler product line marketed in Australia.
• Regenera Activa AMT
• E-50 Exosomes
• FACTOR4

Products and services

• Collagen Stimulating Filler

Quantifiable outcome

• 100% of patients reported improved, much improved, or very much improved results at 24 months post-treatment
• +3 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Sinclair CollegecoreStrategic or Co-development PartnerSinclair College offers Austramedex partner physicians online educational courses, training programmes, and webinars. This partnership provides professional development and training resources for healthcare professionals seeking to integrate Austramdex products into their treatment offerings.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Candela Medical: Global aesthetics and medical device company offering laser, energy-based, and skincare technologies into plastic surgery and dermatology practices. Broad incumbent serving the same customer base as Austramedex with complementary (non-overlapping) energy-based devices.
• Merz Aesthetics: Established aesthetic medicine player offering Radiesse (calcium hydroxylapatite biostimulator, comparable to Collagen Stimulating Filler), Belotero, and Ultherapy. Broad incumbent competing across the same aesthetic practice channels.
• Allergan Aesthetics (AbbVie): Aesthetic medicine arm of AbbVie and the global leader in facial injectables (Botox, Juvederm) plus CoolSculpting and SkinMedica. Dominant incumbent with substantially larger sales infrastructure targeting the same plastic surgeon and cosmetic doctor customer base.
• BTL Aesthetics: Global aesthetics device company best known for body contouring (EmSculpt), skin tightening, and HIFU platforms. Sells into the same aesthetic practice channels and increasingly competes in non-surgical rejuvenation alongside threads and biostimulators.
• Galderma: Global aesthetic medicine leader (Restylane, Sculptra) with a broad portfolio of fillers and biostimulators directly competing with Collagen Stimulating Filler and Silhouette Soft, plus professional-channel distribution that dwarfs a boutique operator.

Direct peers

• RegenLab: Swiss-based regenerative medicine company specializing in PRP (RegenACR) and cell-based therapies for orthopedics, dermatology, and aesthetics. Directly overlaps with the FACTOR 4 PRP product and the regenerative medicine positioning of Austramedex.
• Teoxane: Swiss aesthetics company marketing the Teosyal RHA dermal filler range and complementary skincare. Specialty aesthetic boutique comparable to Austramedex in scale and channel focus, with direct overlap in cosmetic doctor targeting.
• Croma-Pharma: Austrian aesthetics company specializing in hyaluronic acid fillers (Princess range), thread lifts, and PRP — directly comparable in product mix and channel (plastic surgeons, dermatologists). A mid-sized direct competitor in the boutique aesthetic device space.
• Sinclair Pharma: UK-based aesthetic medicine company that owns the Silhouette Soft thread lift and Ellansé Collagen Stimulating Filler brands that Austramedex distributes in Australia. Direct principal-distributor relationship and overlapping product portfolio in aesthetic medicine.

Emerging players

• Cutera: Aesthetic device company offering laser, light, and energy-based platforms (enLIGHTen, excel V, truSculpt) to plastic surgeons, dermatologists, and aesthetic practices. Comparable distribution channel and practitioner customer base with emerging product overlap in regenerative / rejuvenation segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CollagenAustralia
• Instagraminstagram.com/collagen_filler_australia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Austramedex